Safety and Effectiveness of Sonu for Pediatric Nasal Congestion

Last updated: September 8, 2025
Sponsor: Third Wave Therapeutics
Overall Status: Completed

Phase

N/A

Condition

Inflammation

Acute Rhinitis

Nasal Obstruction

Treatment

Acoustic Resonance (Sound) Therapy

Clinical Study ID

NCT06773013
CP-008
  • Ages 12-21
  • All Genders

Study Summary

To demonstrate the safety and effectiveness of Sonu for the treatment of pediatric patients with moderate to severe nasal congestion.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Pediatric subjects between the ages of 12 to 21 years

  • Present with symptoms of nasal congestion for 1 month or more prior to treatment

  • Have a 24 hour reflective nasal congestion subscore of the TNSS of 2 or more on a 0to 3 scale at the time of screening

Exclusion

Exclusion Criteria:

  • Head, nasal or sinus surgery within 3 months

  • Sinus infection diagnosed within the last month, or rhinitis medicamentosa

  • Documented history of nasal polyposis or mass

  • Pregnancy

Study Design

Total Participants: 31
Treatment Group(s): 1
Primary Treatment: Acoustic Resonance (Sound) Therapy
Phase:
Study Start date:
January 09, 2025
Estimated Completion Date:
March 30, 2025

Connect with a study center

  • Crescendo MD

    Portola Valley, California 94028
    United States

    Site Not Available

  • Crescendo MD

    Portola Valley 5384478, California 5332921 94028
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.